Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
Clinical trial NCT04036435 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04036435
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2026-07-25
- Enrollment
- 1466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.